在帕金森病的老年人中,定时上肢评估的发展和初始心理特征
Kristie Harper1,2,3, Angela Jacques4, Melanie Burton1
1Sir Charles Gairdner Osborne Park Health Care Group, Occupational Therapy, Perth, WA, Australia.
The British journal of occupational therapy
|September 3, 2025
概括
定时上肢评估 (TULA) 是评估帕金森病上肢功能的一种可靠工具. 它显示出良好的有效性,并可以帮助职业治疗评估.
科学领域:
- 神经学
- 康复医学
- 运动障碍
背景情况:
- 上肢功能障碍是帕金森病患者常见的问题.
- 需要对帕金森病上肢运动缺陷进行验证的功能评估工具.
研究的目的:
- 试验并确定定时上肢评估 (TULA) 的初始心理特征.
- 评估TULA作为上肢功能的10项定时功能评估工具.
主要方法:
- 一项前性观察性研究涉及381名参与者 (202名帕金森病患者,179名对照患者).
- 给出了TULA,在一个子集中评估了评价者之间的可靠性 (n=47).
- 通过主要成分分析检查结构有效性,并通过认知和运动评估的相关性来检查收有效性.
主要成果:
- 图拉显示出高的内部一致性 (克朗巴赫α=0. 81) 和评价者之间的可靠性 (ICC>0. 9).
- 与对照组相比,患有帕金森病的参与者完成时间显著长 (p < 0. 001).
- 与已确定的运动和认知评估有中等到低的相关性.
结论:
- 对于患有帕金森病的人来说,TULA是一种可靠且有效的上肢功能评估工具.
- 这种工具可以作为帕金森病护理中职业治疗干预的宝贵资源.
相关概念视频
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K


